Status:
UNKNOWN
Clinical Evaluation of Acupuncture Treatment for Negative Symptoms of Schizophrenia
Lead Sponsor:
Shanghai Mental Health Center
Conditions:
Schizophrenia
Eligibility:
All Genders
18-60 years
Phase:
PHASE4
Brief Summary
To explore the effects of combined traditional Chinese and Western medicine( Chinese acupuncture combined with Amisulpride Tablets) on negative symptoms, cognitive function and social function in pati...
Detailed Description
Our research hypothesis：1. Medically assisted Acupuncture in schizophrenia can improve negative symptoms；2. Drug assisted Acupuncture Therapy has better cognitive function in schizophrenic patients th...
Eligibility Criteria
Inclusion
- The diagnosis of schizophrenia according to International classification diagnosis-10(ICD-10)
- patients at an age between 18～60 years old of Han nationality
Exclusion
- other psychiatric diagnoses
- Suffering from serious physical disease and can not accept the treatment
- Patients to be diagnosed according to ICD-10 for substance abused, development delayed
- Inability to sign informed consent because of capacity due due to severe mental illness, significant psychomotor agitation or slowness test completion
- claustrophobic
- metal implantation in vivo
Key Trial Info
Start Date :
October 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2019
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03802838
Start Date
October 1 2017
End Date
September 30 2019
Last Update
January 14 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shanghai Mental Health Center
Shanghai, Shanghai Municipality, China, 200030